HealthQuill Europe
ARS Pharmaceuticals, a US-based biopharmaceutical company, got the nation’s drug regulator’s approval for a nasal spray to treat allergic reactions in adult and paediatric patients.
Pharma

Danish Pharma ALK pays ARS $145m for Neffy nasal spray licensing deal

HQ Team November 13, 2024: ALK-Abelló, the Danish pharma company has acquired exclusive rights to Neffy (epinephrine nasal spray) from ARS Pharmaceuticals for.

Read More
Astellas Pharma Inc.’s therapy to treat a form of gastric cancer got approval from the US drug regulator, according to a company statement.
Drugs Health Pharma

Astellas Pharma gets US regulator’s nod for its gastric cancer drug 

Astellas Pharma Inc.’s therapy to treat a form of gastric cancer got approval from the US drug regulator, according to a company statement.

Read More
Twenty-four European universities have formed a network to impart skills to 10,000 medical students across undergraduate degree programmes to address current and future climate-related health threats, according to a  statement from the University of Glasgow.
Climate Health Pharma

European body to teach medical students health risks from climate change

Twenty-four European universities have formed a network to impart skills to 10,000 medical students across undergraduate degree programmes to address current and future.

Read More
Glaciers suffered the largest mass loss in 50 years as last year marked the driest for global rivers in 33 years, according to a World Meteorological Organization report.
Climate Health Pharma

Global glaciers suffer largest mass loss in 50 yrs, 2023 driest for rivers

Glaciers suffered the largest mass loss in 50 years as last year marked the driest for global rivers in 33 years, according to.

Read More
Pfizer Inc.’s sickle cell therapy involving Oxbryta has been voluntarily withdrawn from global markets due to painful complications and death, according to a company statement.
Drugs Health Pharma

Pfizer pulls out sickle cell therapy from global markets, cites death, snags

Pfizer Inc.’s sickle cell therapy involving Oxbryta has been voluntarily withdrawn from global markets due to painful complications and death, according to a.

Read More
Falling global wages, possibly driven by automation and artificial intelligence, will slow the pace of achieving Sustainable Development Goals (SDG) as the 2030 deadline looms, according to an International Labour Organization report.
Drugs Health Medical

SDG targets in danger as paychecks shrink globally, ILO says

Falling global wages, possibly driven by automation and artificial intelligence, will slow the pace of achieving Sustainable Development Goals (SDG) as the 2030.

Read More
The World Health Organization expects the first delivery of mpox vaccines, made by Bavarian Nordic and donated by the European Union, today in Congo — the outbreak's epicentre.
Drugs Health Pharma

First batch of Bavarian Nordic’s mpox vaccines in Congo by Sept. 5 

The World Health Organization expects the first delivery of mpox vaccines, made by Bavarian Nordic and donated by the European Union, today in.

Read More
Switzerland’s Basilea Pharmaceutica Ltd. will receive $1.25 million from its partner Pfizer Inc. after the latter exceeded the sales target for a licensed anti-fungal drug in the Asia-Pacific region and China.
Drugs Medical Pharma

Basilea Pharmaceutica to get $1.25m license fee from Pfizer

Switzerland’s Basilea Pharmaceutica Ltd. will receive $1.25 million from its partner Pfizer Inc. after the latter exceeded the sales target for a licensed.

Read More
WHO issues global warning on drug-resistant Klebsiella Pneumonie pathogen
Drugs Health Pharma

WHO warns on drug-resistant Klebsiella Pneumonie spread

HQ Team August 4, 2024: The WHO has warned about the rising global incidence of hypervirulent and multi-resistant Klebsiella Pneumoniae (hvKp) infections. The.

Read More
About 24% of adolescent girls or close to 19 million globally have experienced physical or sexual violence by their intimate partner by the time they turn 20 years old, according to a WHO-funded report.
Drugs Health Pharma

A quarter of global adolescent girls face violence by intimate partners: WHO

About 24% of adolescent girls or close to 19 million globally have experienced physical or sexual violence by their intimate partner by the.

Read More